Report cover image

Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Published Aug 25, 2025
Length 320 Pages
SKU # FCSL20346397

Description

The global lateral flow assay market size is likely to be valued at US$ 9.9 Bn in 2025 and is estimated to reach US$ 14.1 Bn by 2032, growing at a CAGR of 5.18% during the forecast period from 2025 to 2032. Lateral flow assays (LFAs) are rapid, simple, and cost-effective diagnostic devices used for qualitative and semi-quantitative detection of various analytes in clinical, veterinary, food safety, and environmental applications. Their demand is driven by increasing disease prevalence, growing adoption of point-of-care testing, and advancements in diagnostic technologies. The market is witnessing higher penetration in both developed and emerging economies, driven by the urgent need for early detection and preventive healthcare.

Lateral Flow Assay Market – Report Scope

The lateral flow assay market encompasses a broad range of diagnostic devices designed to detect target analytes, including pathogens, biomarkers, and contaminants. These assays are widely used in applications such as infectious disease testing, pregnancy detection, drug of abuse testing, and chronic disease monitoring. LFAs are popular for their rapid turnaround time, portability, and minimal need for specialized training. The growing focus on decentralized diagnostics, coupled with increasing awareness of early disease detection, is accelerating adoption worldwide.

Key Market Drivers

Several factors are fueling the growth of the global lateral flow assay market. The rising prevalence of infectious diseases, such as HIV, malaria, and respiratory infections, has significantly increased the demand for rapid and accurate testing solutions. Growing awareness about preventive healthcare and the advantages of point-of-care diagnostics, such as immediate results and minimal infrastructure requirements, is further boosting adoption. Technological advancements, including digital and connected LFA readers, are enhancing test accuracy and usability. Moreover, the increasing burden of chronic diseases such as diabetes is creating consistent demand for regular monitoring using LFAs. The COVID-19 pandemic also acted as a strong catalyst, normalizing the use of rapid diagnostic kits globally.

Market Restraints

Despite strong growth prospects, the market faces certain challenges. The risk of false-positive or false-negative results in LFAs can limit their reliability for critical diagnostics. In many cases, confirmatory testing is required, increasing the overall cost and time of diagnosis. Stringent regulatory requirements for new diagnostic devices can also slow product approvals. Additionally, competition from other diagnostic technologies, such as PCR and ELISA, which offer higher sensitivity, can restrain market penetration in certain applications. Price sensitivity in low- and middle-income countries can further hinder adoption, especially for advanced LFA devices.

Emerging Business Opportunities

The lateral flow assay market offers substantial growth opportunities driven by expanding applications in home-based and self-testing kits. The integration of smartphone connectivity with LFA readers for real-time result sharing and telehealth consultations is emerging as a key innovation trend. Increasing investments in developing LFAs for non-communicable diseases, food safety testing, and environmental monitoring can open new revenue streams. Moreover, the expansion of distribution channels through e-commerce platforms and retail pharmacies is improving accessibility. Strategic partnerships between diagnostic companies and healthcare organizations in emerging economies will further drive market penetration.

Regional Outlook
• North America remains a dominant market due to advanced healthcare infrastructure, high adoption of point-of-care testing, and strong presence of leading diagnostic companies. The U.S. leads the region, supported by extensive R&D and high awareness of preventive diagnostics.
• Europe holds a significant share, driven by strong government initiatives for disease prevention and growing investments in healthcare innovation, with Germany, the U.K., and France at the forefront.
• Asia Pacific is expected to witness the fastest growth, fueled by a rising population, increasing healthcare expenditure, and high demand for affordable diagnostic solutions in countries such as China and India.
• Latin America is gaining momentum due to growing awareness of infectious diseases and improving diagnostic capabilities in countries like Brazil and Mexico.
• Middle East & Africa present emerging opportunities, supported by healthcare modernization programs and a growing focus on early disease detection.

Leading Companies

Leading companies in the global lateral flow assay market, such as Thermo Fisher Scientific Inc., F. Hoffmann-La Roche, Abbott Laboratories, and Becton, Dickinson & Company, are investing heavily in product innovation, user-friendly designs, and strategic collaborations to strengthen their market presence. These companies are focusing on expanding their product portfolios to address a wide range of diagnostic applications, from infectious disease detection to chronic condition monitoring. Expanding distribution networks, especially in developing regions, and integrating digital technologies into LFA readers are key strategies driving their competitive advantage.

Companies Covered in This Report:
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche
• Abbott Laboratories
• Becton, Dickinson & Company
• PerkinElmer Inc.
• Siemens Healthineers
• QIAGEN N.V.
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Maternova Inc.
• Quidel Corporation
• Healgen Scientific, LLC.
• Meridian Bioscience Inc.
• Abcam plc.
• Access Bio, Inc.
• Humasis Co. Ltd.
• DIALUNOX GmbH
• Detekt Biomedical LLC
• Guangzhou Wondfo Biotech Co., Ltd.
• Creative Diagnostics

Market Segmentation

By Product Type
• LFA Readers
Benchtop Readers
Handheld Readers
• LFA Kits
Test Strips
Dipsticks
Cassettes
Lancets

By Application
• Sexually Transmitted Diseases
Human Deficiency Virus (HIV) Infection
Gonorrhoea
Syphilis
Others
• Infectious Diseases
Mosquito-Borne Diseases
Streptococcus Infections
Hepatitis Infection
Gastrointestinal Infections
Respiratory Tract Infections
Others
• Diabetes
• Pregnancy and Fertility Testing
• Drug of Abuse Testing

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Supermarkets/Hypermarkets
• e-Commerce

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: Delivery Timelines - 5 working days.

Table of Contents

320 Pages
1. Executive Summary
1.1. Global Lateral Flow Assay Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019-2024
3.1. Global Lateral Flow Assay Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2019-2024
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019-2024
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019-2024
4.2. Prominent Factor Affecting Lateral Flow Assay Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Lateral Flow Assay Market Outlook, 2019-2032
5.1. Global Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
5.1.1. Key Highlights
5.1.1.1. LFA Readers
5.1.1.1.1. Benchtop Readers
5.1.1.1.2. Handheld Readers
5.1.1.2. LFA Kits
5.1.1.2.1. Test Strips
5.1.1.2.2. Dipsticks
5.1.1.2.3. Cassettes
5.1.1.2.4. Lancets
5.2. Global Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Sexually Transmitted Diseases
5.2.1.1.1. Human Deficiency Virus (HIV) Infection
5.2.1.1.2. Gonorrhoea
5.2.1.1.3. Syphilis
5.2.1.1.4. Others
5.2.1.2. Infectious Diseases
5.2.1.2.1. Mosquito-Borne Diseases
5.2.1.2.2. Streptococcus Infections
5.2.1.2.3. Hepatitis Infection
5.2.1.2.4. Gastrointestinal Infections
5.2.1.2.5. Respiratory Tract Infections
5.2.1.2.6. Others
5.2.1.3. Diabetes
5.2.1.4. Pregnancy and Fertility Testing
5.2.1.5. Drug of Abuse Testing
5.3. Global Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. Supermarkets/Hypermarkets
5.3.1.4. e-Commerce
5.4. Global Lateral Flow Assay Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019-2032
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Lateral Flow Assay Market Outlook, 2019-2032
6.1. North America Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
6.1.1. Key Highlights
6.1.1.1. LFA Readers
6.1.1.1.1. Benchtop Readers
6.1.1.1.2. Handheld Readers
6.1.1.2. LFA Kits
6.1.1.2.1. Test Strips
6.1.1.2.2. Dipsticks
6.1.1.2.3. Cassettes
6.1.1.2.4. Lancets
6.2. North America Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Sexually Transmitted Diseases
6.2.1.1.1. Human Deficiency Virus (HIV) Infection
6.2.1.1.2. Gonorrhoea
6.2.1.1.3. Syphilis
6.2.1.1.4. Others
6.2.1.2. Infectious Diseases
6.2.1.2.1. Mosquito-Borne Diseases
6.2.1.2.2. Streptococcus Infections
6.2.1.2.3. Hepatitis Infection
6.2.1.2.4. Gastrointestinal Infections
6.2.1.2.5. Respiratory Tract Infections
6.2.1.2.6. Others
6.2.1.3. Diabetes
6.2.1.4. Pregnancy and Fertility Testing
6.2.1.5. Drug of Abuse Testing
6.3. North America Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. Supermarkets/Hypermarkets
6.3.1.4. e-Commerce
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1. Key Highlights
6.4.1.1. U.S. Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1.2. U.S. Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1.3. U.S. Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1.4. Canada Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1.5. Canada Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.1.6. Canada Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Lateral Flow Assay Market Outlook, 2019-2032
7.1. Europe Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.1.1. Key Highlights
7.1.1.1. LFA Readers
7.1.1.1.1. Benchtop Readers
7.1.1.1.2. Handheld Readers
7.1.1.2. LFA Kits
7.1.1.2.1. Test Strips
7.1.1.2.2. Dipsticks
7.1.1.2.3. Cassettes
7.1.1.2.4. Lancets
7.2. Europe Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Sexually Transmitted Diseases
7.2.1.1.1. Human Deficiency Virus (HIV) Infection
7.2.1.1.2. Gonorrhoea
7.2.1.1.3. Syphilis
7.2.1.1.4. Others
7.2.1.2. Infectious Diseases
7.2.1.2.1. Mosquito-Borne Diseases
7.2.1.2.2. Streptococcus Infections
7.2.1.2.3. Hepatitis Infection
7.2.1.2.4. Gastrointestinal Infections
7.2.1.2.5. Respiratory Tract Infections
7.2.1.2.6. Others
7.2.1.3. Diabetes
7.2.1.4. Pregnancy and Fertility Testing
7.2.1.5. Drug of Abuse Testing
7.3. Europe Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacies
7.3.1.2. Retail Pharmacies
7.3.1.3. Supermarkets/Hypermarkets
7.3.1.4. e-Commerce
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Germany Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.2. Germany Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.3. Germany Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.4. U.K. Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.5. U.K. Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.6. U.K. Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.7. France Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.8. France Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.9. France Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.10. Italy Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.11. Italy Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.12. Italy Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.13. Turkey Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.14. Turkey Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.15. Turkey Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.16. Russia Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.17. Russia Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.18. Russia Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.19. Rest of Europe Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.20. Rest of Europe Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.1.21. Rest of Europe Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Lateral Flow Assay Market Outlook, 2019-2032
8.1. Asia Pacific Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.1.1. Key Highlights
8.1.1.1. LFA Readers
8.1.1.1.1. Benchtop Readers
8.1.1.1.2. Handheld Readers
8.1.1.2. LFA Kits
8.1.1.2.1. Test Strips
8.1.1.2.2. Dipsticks
8.1.1.2.3. Cassettes
8.1.1.2.4. Lancets
8.2. Asia Pacific Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Sexually Transmitted Diseases
8.2.1.1.1. Human Deficiency Virus (HIV) Infection
8.2.1.1.2. Gonorrhoea
8.2.1.1.3. Syphilis
8.2.1.1.4. Others
8.2.1.2. Infectious Diseases
8.2.1.2.1. Mosquito-Borne Diseases
8.2.1.2.2. Streptococcus Infections
8.2.1.2.3. Hepatitis Infection
8.2.1.2.4. Gastrointestinal Infections
8.2.1.2.5. Respiratory Tract Infections
8.2.1.2.6. Others
8.2.1.3. Diabetes
8.2.1.4. Pregnancy and Fertility Testing
8.2.1.5. Drug of Abuse Testing
8.3. Asia Pacific Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospital Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. Supermarkets/Hypermarkets
8.3.1.4. e-Commerce
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1. Key Highlights
8.4.1.1. China Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.2. China Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.3. China Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.4. Japan Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.5. Japan Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.6. Japan Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.7. South Korea Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.8. South Korea Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.9. South Korea Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.10. India Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.11. India Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.12. India Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.13. Southeast Asia Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.14. Southeast Asia Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.15. Southeast Asia Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.16. Rest of Asia Pacific Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.17. Rest of Asia Pacific Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.1.18. Rest of Asia Pacific Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Lateral Flow Assay Market Outlook, 2019-2032
9.1. Latin America Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
9.1.1. Key Highlights
9.1.1.1. LFA Readers
9.1.1.1.1. Benchtop Readers
9.1.1.1.2. Handheld Readers
9.1.1.2. LFA Kits
9.1.1.2.1. Test Strips
9.1.1.2.2. Dipsticks
9.1.1.2.3. Cassettes
9.1.1.2.4. Lancets
9.2. Latin America Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
9.2.1.1. Sexually Transmitted Diseases
9.2.1.1.1. Human Deficiency Virus (HIV) Infection
9.2.1.1.2. Gonorrhoea
9.2.1.1.3. Syphilis
9.2.1.1.4. Others
9.2.1.2. Infectious Diseases
9.2.1.2.1. Mosquito-Borne Diseases
9.2.1.2.2. Streptococcus Infections
9.2.1.2.3. Hepatitis Infection
9.2.1.2.4. Gastrointestinal Infections
9.2.1.2.5. Respiratory Tract Infections
9.2.1.2.6. Others
9.2.1.3. Diabetes
9.2.1.4. Pregnancy and Fertility Testing
9.2.1.5. Drug of Abuse Testing
9.3. Latin America Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.3.1. Key Highlights
9.3.1.1. Hospital Pharmacies
9.3.1.2. Retail Pharmacies
9.3.1.3. Supermarkets/Hypermarkets
9.3.1.4. e-Commerce
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1. Key Highlights
9.4.1.1. Brazil Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.2. Brazil Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.3. Brazil Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.4. Mexico Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.5. Mexico Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.6. Mexico Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.7. Argentina Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.8. Argentina Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.9. Argentina Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.10. Rest of Latin America Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.11. Rest of Latin America Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.1.12. Rest of Latin America Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Lateral Flow Assay Market Outlook, 2019-2032
10.1. Middle East & Africa Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
10.1.1. Key Highlights
10.1.1.1. LFA Readers
10.1.1.1.1. Benchtop Readers
10.1.1.1.2. Handheld Readers
10.1.1.2. LFA Kits
10.1.1.2.1. Test Strips
10.1.1.2.2. Dipsticks
10.1.1.2.3. Cassettes
10.1.1.2.4. Lancets
10.2. Middle East & Africa Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
10.2.1. Key Highlights
10.2.1.1. Sexually Transmitted Diseases
10.2.1.1.1. Human Deficiency Virus (HIV) Infection
10.2.1.1.2. Gonorrhoea
10.2.1.1.3. Syphilis
10.2.1.1.4. Others
10.2.1.2. Infectious Diseases
10.2.1.2.1. Mosquito-Borne Diseases
10.2.1.2.2. Streptococcus Infections
10.2.1.2.3. Hepatitis Infection
10.2.1.2.4. Gastrointestinal Infections
10.2.1.2.5. Respiratory Tract Infections
10.2.1.2.6. Others
10.2.1.3. Diabetes
10.2.1.4. Pregnancy and Fertility Testing
10.2.1.5. Drug of Abuse Testing
10.3. Middle East & Africa Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.3.1. Key Highlights
10.3.1.1. Hospital Pharmacies
10.3.1.2. Retail Pharmacies
10.3.1.3. Supermarkets/Hypermarkets
10.3.1.4. e-Commerce
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1. Key Highlights
10.4.1.1. GCC Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.2. GCC Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.3. GCC Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.4. South Africa Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.5. South Africa Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.6. South Africa Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.7. Egypt Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.8. Egypt Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.9. Egypt Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.10. Nigeria Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.11. Nigeria Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.12. Nigeria Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.13. Rest of Middle East & Africa Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.14. Rest of Middle East & Africa Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.1.15. Rest of Middle East & Africa Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2019-2032
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By End User vs by Clinical Application Heat map
11.2. Manufacturer vs by Clinical Application Heatmap
11.3. Company Market Share Analysis, 2025
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. ThermoFisher Scientific Inc.
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. F. Hoffmann-La Roche
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Abbott Laboratories
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. Becton, Dickinson & Company
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. PerkinElmer Inc.
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. Siemens Healthineers
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. QIAGEN N.V.
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
11.5.8. bioMérieux SA
11.5.8.1. Company Overview
11.5.8.2. Product Portfolio
11.5.8.3. Financial Overview
11.5.8.4. Business Strategies and Development
11.5.9. Bio-Rad Laboratories, Inc.
11.5.9.1. Company Overview
11.5.9.2. Product Portfolio
11.5.9.3. Financial Overview
11.5.9.4. Business Strategies and Development
11.5.10. Maternova Inc.
11.5.10.1. Company Overview
11.5.10.2. Product Portfolio
11.5.10.3. Financial Overview
11.5.10.4. Business Strategies and Development
11.5.11. Quidel Corporation
11.5.11.1. Company Overview
11.5.11.2. Product Portfolio
11.5.11.3. Financial Overview
11.5.11.4. Business Strategies and Development
11.5.12. Healgen Scientific, LLC.
11.5.12.1. Company Overview
11.5.12.2. Product Portfolio
11.5.12.3. Financial Overview
11.5.12.4. Business Strategies and Development
11.5.13. Meridian Bioscience Inc.
11.5.13.1. Company Overview
11.5.13.2. Product Portfolio
11.5.13.3. Financial Overview
11.5.13.4. Business Strategies and Development
11.5.14. Abcam plc.
11.5.14.1. Company Overview
11.5.14.2. Product Portfolio
11.5.14.3. Financial Overview
11.5.14.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.